With the increasing numbers of drug-resistant epilepsies resulting from SCN2A and SCN8A mutations being reported, there is increasing opportunity to gather the necessary data to investigate the potential link between neurotransmitters and voltage-gated sodium channelopathies. Here, SCN2A is linked to epilepsy.